NO20063973L - Nye kombinasjoner av et anti emetisk middel og en enkefalinase inhibitor - Google Patents

Nye kombinasjoner av et anti emetisk middel og en enkefalinase inhibitor

Info

Publication number
NO20063973L
NO20063973L NO20063973A NO20063973A NO20063973L NO 20063973 L NO20063973 L NO 20063973L NO 20063973 A NO20063973 A NO 20063973A NO 20063973 A NO20063973 A NO 20063973A NO 20063973 L NO20063973 L NO 20063973L
Authority
NO
Norway
Prior art keywords
new combinations
enkephalinase inhibitor
anti emetic
emetic
combinations
Prior art date
Application number
NO20063973A
Other languages
English (en)
Other versions
NO337320B1 (no
Inventor
Jean-Charles Schwartz
Jeanne-Marie Lecomte
Original Assignee
Bioprojet Soc Civ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34684783&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20063973(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioprojet Soc Civ filed Critical Bioprojet Soc Civ
Publication of NO20063973L publication Critical patent/NO20063973L/no
Publication of NO337320B1 publication Critical patent/NO337320B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Foreliggende oppfinnelse vedrører nye kombinasjoner av et anti-emetisk middel og en enkefalinaseinhibitor, anvendelser av nevnte kombinasjoner for behandling av diaré og/eller gastroentritt.
NO20063973A 2004-02-12 2006-09-05 Kombinasjoner av en 5-HT3 receptor antagonist med racecadotril eller dexecadotril samt anvendelse derav og farmasøytisk sammensetning NO337320B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04290384A EP1563848A1 (en) 2004-02-12 2004-02-12 New combinations of an anti-emetic agent and an enkephalinase inhibitor
PCT/IB2005/000351 WO2005079850A1 (en) 2004-02-12 2005-02-14 New combinations of an anti emetic agent and an enkephalinase inhibitor

Publications (2)

Publication Number Publication Date
NO20063973L true NO20063973L (no) 2006-09-05
NO337320B1 NO337320B1 (no) 2016-03-07

Family

ID=34684783

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063973A NO337320B1 (no) 2004-02-12 2006-09-05 Kombinasjoner av en 5-HT3 receptor antagonist med racecadotril eller dexecadotril samt anvendelse derav og farmasøytisk sammensetning

Country Status (28)

Country Link
US (1) US8222294B2 (no)
EP (2) EP1563848A1 (no)
JP (1) JP4987487B2 (no)
KR (1) KR101152308B1 (no)
CN (1) CN1917903B (no)
AT (1) ATE468138T1 (no)
AU (1) AU2005215262B2 (no)
BR (1) BRPI0506631B8 (no)
CA (1) CA2553827C (no)
CY (1) CY1110202T1 (no)
DE (1) DE602005021317D1 (no)
DK (1) DK1718337T3 (no)
EA (1) EA010625B1 (no)
EC (1) ECSP066758A (no)
ES (1) ES2344909T3 (no)
HR (1) HRP20100363T1 (no)
MA (1) MA28354A1 (no)
ME (1) ME01175B (no)
NO (1) NO337320B1 (no)
NZ (1) NZ548635A (no)
PL (1) PL1718337T3 (no)
PT (1) PT1718337E (no)
RS (1) RS51329B (no)
SI (1) SI1718337T1 (no)
TN (1) TNSN06246A1 (no)
UA (1) UA88156C2 (no)
WO (1) WO2005079850A1 (no)
ZA (1) ZA200605872B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2900823B1 (fr) * 2006-05-15 2009-02-13 Bioprojet Soc Civ Ile Nouvelle forme d'administration du racecadotril.
EP2462922A1 (en) * 2010-12-10 2012-06-13 Bioprojet New form of administration of enkephalinase inhibitor
EP2866802B1 (en) * 2012-06-28 2016-07-27 Johnson & Johnson Consumer Inc. Racecadotril liquid compositions
US9801819B2 (en) * 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
RU2632441C2 (ru) 2012-06-28 2017-10-04 МакНЕЙЛ-ППС, ИНК. Липидные композиции рацекадотрила
US9114171B2 (en) * 2012-06-28 2015-08-25 Mcneil-Ppc, Inc. Racecadotril liquid compositions
MA40859A (fr) 2014-10-29 2017-09-05 Johnson & Johnson Consumer Inc Particules de cadotril

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins

Also Published As

Publication number Publication date
EP1563848A1 (en) 2005-08-17
CN1917903B (zh) 2010-07-21
PT1718337E (pt) 2010-06-16
CA2553827A1 (en) 2005-09-01
AU2005215262B2 (en) 2011-03-03
PL1718337T3 (pl) 2010-09-30
NO337320B1 (no) 2016-03-07
WO2005079850A1 (en) 2005-09-01
BRPI0506631B8 (pt) 2021-05-25
JP2007522202A (ja) 2007-08-09
RS51329B (sr) 2011-02-28
BRPI0506631A (pt) 2007-05-08
ATE468138T1 (de) 2010-06-15
BRPI0506631B1 (pt) 2018-12-04
NZ548635A (en) 2009-10-30
UA88156C2 (ru) 2009-09-25
TNSN06246A1 (fr) 2007-12-03
HRP20100363T1 (hr) 2010-07-31
CA2553827C (en) 2012-08-07
EP1718337A1 (en) 2006-11-08
ECSP066758A (es) 2006-11-24
US8222294B2 (en) 2012-07-17
DE602005021317D1 (de) 2010-07-01
MA28354A1 (fr) 2006-12-01
KR101152308B1 (ko) 2012-06-11
DK1718337T3 (da) 2010-07-26
ES2344909T3 (es) 2010-09-09
EA010625B1 (ru) 2008-10-30
SI1718337T1 (sl) 2010-08-31
EA200601466A1 (ru) 2006-12-29
EP1718337B1 (en) 2010-05-19
ME01175B (me) 2013-03-20
CN1917903A (zh) 2007-02-21
JP4987487B2 (ja) 2012-07-25
CY1110202T1 (el) 2015-01-14
KR20060132691A (ko) 2006-12-21
US20070275993A1 (en) 2007-11-29
ZA200605872B (en) 2008-01-08
AU2005215262A1 (en) 2005-09-01

Similar Documents

Publication Publication Date Title
CR9869A (es) Compuestos activos en ppar
NO20083147L (no) Anti-OX40L-antistoffer og fremgangsmater for anvendelse av disse
CO2021005884A2 (es) Moduladores de la alfa-1 antitripsina
DK1685247T3 (da) Vektorer til retningsbestemt kloning
DE602007009663D1 (de) Pyridonsulfonamide und pyridonsulfamide als mek-hemmer
NZ595225A (en) Use of tnf inhibitor for treatment of erosive polyarthritis
EA201000888A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и 2-фенилциклогексан-1,3,5-трионы в качестве гербицидов
DE602006008643D1 (de) Ophthalmische Zusammensetzungen von parasympathischen Stimulantia und Entzündungshemmer zur Verwendung bei der Behandlung von Presbyopie
BRPI0608886B8 (pt) derivados de n-sulfonilpirróis e seus usos
NO20075412L (no) Fremgangsmater og preparater til modulering av hyperstabilisert C-MET
CY1110202T1 (el) Νεοι συνδυασμοι ενος αντι εμετικου παραγοντα και ενος αναστολεα της εγκεφαλινασης
NO20083397L (no) Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse
DE602004019812D1 (de) Marker für neuromyelitis optica
BRPI0413969A (pt) modulação da transcrição ativada por -catenina/tcf
NO20083593L (no) Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse
DOP2025000055A (es) Moduladores de la alfa-1 antitripsina
EA201000566A1 (ru) Гетероциклические сетр ингибиторы
NO20033921L (no) Inhibitor av monoaminopptak
TW200712130A (en) Process oil and rubber composition
DE602005012551D1 (de) Abbaubare polymere und herstellungsverfahren dafür
DK1819354T3 (da) Fremgangsmåder og forbindelser til behandling af diabetes
UA45142S (uk) 1.-8. тумба
ATE344041T1 (de) Kombination eines gelatinasehemmers und eines anti-tumor-agent, und deren verwendung
CR7953A (es) Derivados azabiciclicos de piridiloximetilo bencisoxazol
ES1059725Y (es) Colgante para telefono movil, aparatos de sonido, aparatos fotograficos o similares.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees